0001062993-24-005773.txt : 20240306
0001062993-24-005773.hdr.sgml : 20240306
20240306194523
ACCESSION NUMBER: 0001062993-24-005773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEUPERT PETER M
CENTRAL INDEX KEY: 0001237566
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 24727780
MAIL ADDRESS:
STREET 1: 13920 SE EASTGATE WAY
STREET 2: STE 300
CITY: BELLEVUE
STATE: WA
ZIP: 98005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-03-04
0001478320
Adaptive Biotechnologies Corp
ADPT
0001237566
NEUPERT PETER M
C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
1165 EASTLAKE AVENUE EAST
SEATTLE
WA
98109
1
0
0
0
0
Common Stock
2024-03-04
4
A
0
31328
0
A
154296
D
Stock Option (right to buy)
3.99
2024-03-04
4
A
0
48044
0
A
2034-03-04
Common Stock
48044
48044
D
The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates.
/s/ Peter M Neupert by Stacy L Taylor, Attorney-in-Fact
2024-03-06